Our commitments
This is what
we stand for

We believe no one should suffer
because of their skin issues

That’s why we partner with dermatologists to understand and answer all skin needs on all continents. We continuously work together with dermatologists, pediatricians and oncologists to develop the most efficient formulas for their patients’ needs, run clinical trials pre-launch and monitor their efficacy overtime. 

For new project and scientific innovations, we consult with our La Roche-Posay expert medical boards made up of doctors from a range of specialties. They work closely with us to co-create products that are very well tolerated, even on skin weakened by medical conditions or procedures.

We pioneer
scientific
innovations

Your skin deserves the
most tolerated, most
efficient 
and most useful
dermatological
solutions

For 10 years, we have been radically leading microbiome science
research to bring you useful and efficient innovations, such as Lipikar
AP+M for atopic eczema prone skin. We believe that microbiome
science is the future of skin health and have made 13 publications
and run19 clinical studies on 1200 people since 2011.
discover microbiome science

For 25 years,
Anthelios has been
pioneering sun
protection

Its broad-spectrum, very high protection is the result of advanced clinical research into suncare and sun sensitive skin resulting in 32 clinical studies, 34 publications and 41 scientific posters. Our breakthrough patented Netlock technology™ brings a new level of high protection in an invisible texture.
discover anthelios

 

More recently we have been partnering with dermatologists to develop
technological services, such as Spotscan, to bring expert advice to the
greatest number of people. EFFACLAR SPOTSCAN is a life-changing
innovation that uses artificial intelligence based on extensive scientific
data to make personalized acne diagnosis.
discover spotscan

These scientific innovations
can be found in our iconic
life-changing products

prescribed by
dermatologists every day
and loved by fans across
the world

 
OUR LIFE-CHANGING SKINCARE SOLUTIONS

We strive for
maximum
efficacy &
tolerance

Because we design formulas and services
with real problems in mind

Our obsession:
maximum efficacy
combined with maximum
safety and tolerance

We take a particularly meticulous approach to dermocosmetics
tolerance thanks to ingredient selection criteria, stringent testing
protocols on specific skin concerns and ongoing expert partnerships.

 

our superior dermatological solutions

We aim
to improve 
quality of life

Because 89% of children
with eczema experience
disrupted sleep during
flare ups 

And 60% experience difficulties at school, we specifically designed a
new formula to rebalance the microbiome, soothe and space out
dryness flare-ups. The result: 75% improvement in quality of
sleep for people with eczema-prone skin.
DISCOVER LIPIKAR BAUME AP+M

limiting skin side effects
and improving cancer
patients’ everyday comfort

Our observational and clinical studies have shown the effectiveness of some La Roche-Posay products in limiting skin side effects and improving the skin comfort of cancer patients.

Because 40% of adult
women suffer from acne

Acne continues to be a concern beyond adolescence and some
women with acne-prone skin say they feel ashamed, ugly, and
prisoners of their own skin. This is why we launched Effaclar Serum,
the first ultra-concentrated daily peeling for adult acne-prone skin. It
brings anti-imperfections, anti-marks, visible efficacy from the first
morning and 49% less acne marks in 28 days.
DISCOVER EFFACLAR SERUM

80%* of people with
cancer suffer from
skin side effects of
the cancer
treatments

For over 10 years, we have worked hand in hand with dermatologists and oncologists to develop solutions which limit these skin side effects and improve skin comfort. We have conducted numerous clinical and observational studies with cancer patients to test the efficacy and tolerance of our products.
DISCOVER EFFACLAR SERUM
* Charles C, Sultan S, Bungener C, et al. Impact of cutaneous toxicities associated with targeted therapies on quality of life. Results of a longitudinal exploratory study. Bull Cancer. 2013;100(3):213-222. doi:10.1684/bdc.2013.1709

Our obsession:
make sure everyone is
aware dermatological
solutions exist for
cancer patients

Our observational studies have shown the effectiveness of specific
La Roche-Posay products patients’ everyday skin comfort.
DISCOVER